Chronic tearing, often stemming from blocked tear ducts, affects millions worldwide. A common surgical intervention, endonasal dacryocystorhinostomy (DCR), aims to restore tear drainage. Recent research suggests that adding a silicon stent during this procedure doesn’t significantly alter the success rate, offering surgeons and patients another data point in treatment decisions. The procedure, performed endoscopically, has become increasingly common due to its reduced invasiveness and improved patient outcomes compared to older techniques.
A comparative study conducted in central India investigated the effectiveness of endonasal DCR with and without the use of a silicon stent in patients diagnosed with chronic dacryocystitis – inflammation of the tear sac due to a blockage. Researchers sought to determine if stenting provided a measurable benefit in terms of long-term tear duct patency and symptom relief. The findings, published recently, could influence surgical approaches to this common condition.
Study Details and Methodology
The study, which took place between October 2021 and September 2022, involved 60 patients over the age of 18 experiencing chronic dacryocystitis. Patients with a history of previous dacryocystorhinostomy or significant sinonasal disease were excluded from the study. All surgeries were performed by a single senior surgeon using both zero-degree and 45-degree endoscopes with an Olympus camera and monitor. Patients were divided into two groups of 30: one receiving a silicon stent (Prison silicone nasolacrimal duct stent) and the other undergoing the procedure without stenting. Follow-up evaluations were conducted at three, six, and twelve months post-surgery, utilizing the Chi-square test for statistical analysis.
Comparable Success Rates Observed
The results indicated a high success rate for both groups. At six months, 90% of patients who received a stent experienced successful outcomes, compared to 93.3% in the non-stented group. This difference was not statistically significant (p-value – 0.64). The success rates remained comparable at twelve months, with 80% and 76.6% success rates for the stented and non-stented groups, respectively (p-value – 0.71). Final endoscopic examinations at the twelve-month mark revealed a patent rhinostomy opening in 93.3% of stented patients and 90% of those who did not receive a stent.
Early DCR Shows Promise for Acute Cases
While this study focused on chronic dacryocystitis, other research highlights the potential benefits of early endonasal DCR for acute dacryocystitis. A recent meta-analysis published in PubMed suggests that early intervention can lead to faster symptom resolution and comparable efficacy to delayed procedures. The meta-analysis, encompassing six studies and 288 patients, found that early endonasal DCR significantly reduced the time to resolution of medial canthus swelling (indicate difference -4.92 days) and complete symptom resolution (mean difference -17.70 days).
The increasing use of endoscopic techniques in otorhinolaryngological surgeries has generally led to less invasive procedures and improved patient outcomes. Endoscopic endonasal dacryocystorhinostomy has evolved from functional endoscopic sinus surgery, offering a refined approach to tear duct obstruction.
The study authors concluded that, for patients with chronic dacryocystitis, endonasal DCR with or without stenting yields similar results. This finding may facilitate surgeons tailor treatment plans based on individual patient factors and preferences. Further research may explore the optimal use of stenting in specific patient subgroups.
As advancements continue in endoscopic surgical techniques, the management of tear duct obstruction is likely to become even more precise and effective. Ongoing studies will continue to refine our understanding of the best approaches for both acute and chronic dacryocystitis, ultimately improving patient quality of life.
Disclaimer: This article provides informational content and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
Have you or someone you know experienced issues with blocked tear ducts? Share your thoughts in the comments below.
